hit counter

Fetzima (Levomilnacipran) & Weight Loss vs. Gain

Fetzima (Levomilnacipran) is a medication prescribed for the treatment of major depressive disorder in adults.  Although it is similar to the drug Savella (Milnacipran), Fetzima exhibits unique pharmacodynamics in that it functions as a serotonin-norepinephrine reuptake inhibitor (SNRI) with a 2-fold affinity for norepinephrine reuptake inhibition – relative to serotonin reuptake inhibition. In other words, …

Read more

Fetzima (Levomilnacipran) Withdrawal Symptoms

Fetzima (Levomilnacipran), is a serotonin-norepinephrine reuptake inhibitor (SNRI) that was approved by the United States FDA in 2013 for the treatment of major depressive disorder.  It was engineered to be a spinoff (or some might suggest an upgraded or slightly modified version) of the drug Savella (Milnacipran). Comparatively, Fetzima solely contains the levorotatory enantiomer of …

Read more

Fetzima (Levomilnacipran) Side Effects: List of Possibilities

Fetzima (Levomilnacipran) is a serotonin-norepinephrine reuptake inhibitor that was approved by the FDA in 2013 to treat major depression. It is similar to the older drug milnacipran, but contains the “levo”-stereoisomer – making it slightly different. This antidepressant is regarded as being significantly different from other SNRIs in that it inhibits norepinephrine reuptake to a greater …

Read more

SNRI List: Serotonin Norepinephrine Reuptake Inhibitors

SNRIs (Selective Serotonin Reuptake Inhibitors) are also known as dual-reuptake inhibitors because they prevent the reuptake of multiple neurotransmitters in the brain. Most of the second-generation antidepressants are classified as “SSRI,” meaning they focus solely on preventing the reuptake of serotonin. SNRI drugs continue to prevent the reuptake of serotonin, but also focus on another …

Read more